NXI Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Basel
Business model:B2B

NXI Therapeutics is a Swiss biotech startup developing next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3.85M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to NXI Therapeutics

Name Criteria
Sweden Athera
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Switzerland Bionomous
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Denmark Oui
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Finland FinnAdvance
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Ossiform
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Pharmedigroup
63%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain ViveBiotech
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom CellulaREvolution
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Denmark ResoTher Pharma
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top